Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-003702-95Phase 3Active
Phase 3, randomised trial in Dravet syndrome comparing Topiramate add-on, Stiripentol add-on and High-dose clobazam arm (3 arms). Primary endpoint: Percentage change in clonic or tonic-clonic seizure frequency. Started Sep 2007; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-003702-95.